Autologous dendritic cell-tumor cell immunotherapy

· Lisata Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous dendritic cell-tumor cell immunotherapy, covering 2019-05-10 to 2019-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma [Phase 3]

See pricing